Key takeaways
Clinical trials have not directly compared Ozempic (semaglutide) vs. phentermine for weight loss, but Ozempic generally leads to greater weight loss.
Phentermine is an older weight loss pill typically used short-term, while Ozempic is a daily pill or weekly injectable prescribed for type 2 diabetes or off-label for weight loss.
Phentermine is not safe for everyone because it can affect blood pressure and heart health, among other risks. The low cash price of phentermine makes it a more affordable option, especially for those whose insurance does not cover Ozempic.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
Clinical trials have not directly compared Ozempic (semaglutide) vs. phentermine for weight loss, but Ozempic generally leads to greater weight loss.
Phentermine is an older weight loss pill typically used short-term, while Ozempic is a daily pill or weekly injectable prescribed for type 2 diabetes or off-label for weight loss.
Phentermine is not safe for everyone because it can affect blood pressure and heart health, among other risks. The low cash price of phentermine makes it a more affordable option, especially for those whose insurance does not cover Ozempic.
Phentermine is approved by the US Food and Drug Administration (FDA) for weight management. While Ozempic (semaglutide) is not FDA-approved for weight loss, it can be used off-label for weight loss.
Research suggests Ozempic generally results in more weight loss, but phentermine may be a good option in some cases. Below is a full breakdown of Ozempic vs. phentermine for weight loss.
Phentermine vs. Ozempic at a glance
Ozempic is usually more effective than phentermine for weight loss, with people losing about 15 pounds in nine months at the highest dose of Ozempic.
Semaglutide (the active ingredient in Ozempic) also offers cardiovascular benefits. Phentermine has heart-related risks, which can be an important difference to consider.
Phentermine may be a better option in some cases, such as for those who want a more affordable medication. Phentermine is available as a daily pill. As of May 4, 2026, the pill form of semaglutide under the brand name Rybelsus has been rebranded to the Ozempic pill. Ozempic is available as an injection and as a daily pill.
Here's a quick overview of the two medications:
| Ozempic (semaglutide) | Phentermine |
Medication class | GLP-1 receptor agonist | Sympathomimetic |
FDA-approved for weight loss? | No, used off-label | Yes |
How it works | Mimics a gut hormone that lowers blood sugar levels, reduces appetite, slows digestion | Mild stimulant that suppresses appetite by boosting certain brain chemicals, also increases how much energy you use |
FDA-approved uses | Type 2 diabetes management Cardiovascular risk reduction in type 2 diabetes Kidney protection in type 2 diabetes with kidney disease Off-label: weight management | Short-term weight management in adults with a BMI of 30 or above, or 27 or above with weight-related risk factors. Off-label: long-term weight management |
Form | Injection or oral tablet | Oral tablet, capsule, or disintegrating tablet |
How long to take it | Can be taken long-term | Up to 12 weeks |
Typical dose | Once weekly injection, with a starting dose of 0.25 mg and a maximum dose of 2 mg Daily tablet comes in 1.5 mg, 4 mg, and 9 mg doses | 15 mg, 30 mg, or 37.5 mg daily, or low-dose version of 8 mg three times daily |
Effectiveness for weight loss | Very effective — with an average weight loss of 7%-15% (as Wegovy) long-term, depending on dose | Less effective — with an average weight loss of 5%-10% short term |
Common side effects | Gastrointestinal (GI) symptoms, such as nausea, vomiting, diarrhea, stomach pain | Increased blood pressure, heart rate, insomnia, restlessness, dry mouth, diarrhea, constipation |
Key risks | Risks for pancreatitis, kidney and gallbladder problems, low blood sugar, severe GI symptoms | Small potential for abuse and dependence, potential for worsening heart problems |
Cost, without insurance | About $1,000 monthly for injection and about $200-$300 for pill | As low as $10 monthly |
Key differences between Ozempic and phentermine
1. Ozempic is both an injection and pill, while phentermine only comes as a pill.
2. Ozempic is taken weekly or daily depending on the form; phentermine is taken daily.
3. Ozempic is a GLP-1 agonist, and phentermine is a stimulant.
4. Ozempic is typically longer-term, and phentermine is usually short-term.
5. Ozempic can be used off-label for weight loss; phentermine is approved for weight loss.
6. Ozempic is associated with greater weight loss compared with phentermine.
7. Ozempic can cause digestive issues; phentermine can cause heart and nervous system issues.
8. Ozempic is a brand-name drug that can be costly, while phentermine is a generic medication, which means it’s typically lower in price.
9. Ozempic is not habit-forming; phentermine carries a risk of abuse and dependence and, as such, is a Schedule IV controlled substance.
Ozempic vs. phentermine side effects
Since Ozempic and phentermine belong to different medication classes and work in distinct ways, it is not surprising that their possible side effects differ.
Side effect | Ozempic (semaglutide) | Phentermine |
Stomach Pain | ✅ | ❌ |
Nausea | ✅ | ✅ |
Diarrhea | ✅ | ✅ |
Constipation | ✅ | ✅ |
Trouble sleeping | ❌ | ✅ |
Restlessness, shakiness | ❌ | ✅ |
Fatigue | ✅ | ❌ |
Dry mouth | ❌ | ✅ |
Faster heart rate | ✅ | ✅ |
Headache | ✅ | ✅ |
When used incorrectly, both Ozempic and phentermine can potentially be dangerous. It is important to take only the dose prescribed by a healthcare provider, so they can monitor for some of the more serious complications.
Ozempic side effects
The most common side effects of Ozempic include:
Vomiting
Stomach pain
Dehydration
Low blood sugar (if taken with certain diabetes medications)
Kidney and gallbladder concerns
Pancreatitis
Severe stomach problems
There have also been reports of pulmonary aspiration (stomach contents entering the lungs) during surgery requiring sedation in people taking Ozempic.
Phentermine side effects
While Ozempic’s side effects primarily relate to its impact on digestion, phentermine’s side effects are largely related to its being a mild stimulant. Possible side effects of phentermine include:
Nervousness and excitability
Headache
Dry mouth or thirst
Dizziness
Fast heart rate or palpitations
Increase in blood pressure
Nausea
Constipation
Erectile dysfunction or changes in libido
Dependence and abuse, especially in higher doses
Heart problems like heart valve disease
High blood pressure in the lungs, known as pulmonary hypertension
These effects are similar to some of the effects of other stimulants, such as amphetamines (e.g., Adderall)
Other side effects are possible with either medication. Contact a healthcare provider or seek medical care if side effects do not resolve or seem severe.
Ozempic vs. phentermine: what the science says
Ozempic can lead to greater weight loss than phentermine, based on results from separate studies.
Ozempic and phentermine have not been directly compared in head-to-head clinical trials. When used alongside a nutritious eating plan and regular exercise, either can be effective for weight loss. Individual results will vary.
Ozempic’s effectiveness
Ozempic typically leads to a more substantial reduction in body weight.
In a trial that included people with type 2 diabetes, those taking 1 mg of Ozempic lost about 13 pounds after about nine months, while those taking 2 mg lost about 15 pounds in the same timeframe.
In various studies for type 2 diabetes, people taking 0.5 mg or 1 mg of Ozempic lost 5%–7% of their starting body weight after 7–12 months.
In a trial for obesity, people taking 2.4 mg of semaglutide (Wegovy) lost about 15% of body weight on average over 68 weeks. The participants in this study did not have diabetes.
Phentermine’s effectiveness
Phentermine may help people lose weight more quickly (within a few weeks).
Weight loss with phentermine largely depends on the dose and the duration of use.
It is only FDA-approved for short-term use, based on less long-term clinical data than what is typically required for newer weight loss medications.
Longer use may work better. People who used phentermine for more than a year lost significantly more weight — about 7.4% more at two years — than those who used it for 3 months or less, with no increased risk of heart problems or death.
In an analysis of six studies lasting 2–24 weeks, people taking phentermine lost about 8 pounds more than those on placebo. On average, people taking the drug lost about 14 pounds.
One study found that taking phentermine led participants to lose at least 5% of their body weight after six months.
It may stop working after a while — some people can develop a tolerance to its appetite-suppressing effects.
To put this in perspective, weight loss medications are generally considered successful when a person loses more than 5% of body weight after 12 weeks of treatment at the recommended dosage.
Some healthcare providers may prescribe phentermine long-term or on an intermittent schedule (e.g., several weeks "on" then several weeks "off"), depending on professional judgment and the individual's medical history.
Ozempic vs. phentermine cost
The cash price of Ozempic can be about $1,000 a month for injections and about $200–$300 a month for the oral tablet. The cash price of phentermine can be as low as $10 a month (depending on the pharmacy).
Ozempic tends to cost more than phentermine. Reasons for this include:
Ozempic is only available as a brand-name medication, while phentermine comes in a generic version.
Ozempic is available by injection as well as tablet, and phentermine is available as a tablet only.
Insurance likely will not cover Ozempic for weight loss alone because it is not specifically FDA-approved for this use.
For those taking Ozempic for type 2 diabetes, insurance may cover it. A healthcare provider can advise on whether Wegovy may be an appropriate alternative — it contains the same active ingredient as Ozempic but is FDA-approved for weight loss and has a higher maximum dose.
The Ro Body membership includes insurance verification to simplify navigating coverage.
Who should not take Ozempic or phentermine?
Ozempic and phentermine are safe for most people, but these medications are not right for everyone.
Who shouldn’t take Ozempic?
Ozempic should not be taken by those who are nursing, pregnant, planning to become pregnant, or who have any of the following:
A certain type of thyroid cancer, called medullary thyroid carcinoma (MTC) or a family history of MTC
Multiple endocrine neoplasia type 2 (MEN 2), a disorder that causes tumors in the thyroid and other glands
Certain health conditions may be worsened by Ozempic. A healthcare provider might recommend extra monitoring or a different medication altogether for those with:
Pancreatitis
Diabetic retinopathy
Gallbladder disease
Digestive problems, such as severe gastroparesis
Upcoming surgery that requires sedation
Ozempic may also lead to hypoglycemia (low blood sugar) when combined with insulin or certain diabetes pills (such as glimepiride).
Who shouldn’t take phentermine?
Phentermine should not be taken by those who are pregnant, nursing, or have a history of any of the following:
Heart disease (including high blood pressure, coronary artery disease, heart attack or stroke, or congestive heart failure)
Hyperthyroidism
Glaucoma
Drug abuse or substance use disorder
Agitation (a possible symptom of some mental health conditions)
Phentermine should not be used with alcohol. It should not be taken while taking or within 14 days of stopping an MAOI (monoamine oxidase inhibitor), as this can cause dangerously high blood pressure.
Is it safe to take Ozempic and phentermine together?
It is possible to take Ozempic and phentermine together if a healthcare provider prescribes both. It is unknown whether using the two together is safe or leads to greater weight loss, since the combination has not been studied.
Ozempic and phentermine are not known to interact with each other. However, according to the prescribing information for phentermine, taking it with other weight loss medications is not recommended.
A healthcare provider might still prescribe both if that is the best option. A few things to keep in mind:
Starting on one medication initially is typical. Since semaglutide works well for weight loss, a healthcare provider may not add phentermine — the semaglutide dose may be increased instead.
A second medication may be added if needed. If weight loss results are insufficient, a healthcare provider might add the second medication to potentially improve outcomes.
Taking the medications together can increase side effects. The more medications taken, the greater the chance of side effects. Both may be well tolerated, but a healthcare provider should be informed of any uncomfortable side effects.
Alternatives to Ozempic and phentermine
There are many other medications that can help with weight management, each with different effectiveness, side effects, and costs.
Some of the most common weight loss alternatives to Ozempic and phentermine include:
Wegovy (semaglutide): Unlike Ozempic, Wegovy is FDA-approved for weight loss and is a GLP-1 medication injected weekly or taken as a pill every day.
Zepbound (tirzepatide): A GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), Zepbound is FDA-approved for weight loss and works similarly to other GLP-1s.
Saxenda (liraglutide): A GLP-1 receptor agonist, it’s FDA-approved for weight loss, given as a daily injection.
Qsymia (phentermine/topiramate): A combination medication taken as a daily capsule, Qsymia works better than either medication alone to control overeating and reduce appetite. Unlike phentermine alone, Qsymia is FDA-approved for long-term weight management.
Contrave (naltrexone/bupropion): A combination medication, Contrave is a daily tablet approved for weight management to decrease cravings and appetite. Side effects can include nausea, constipation, and headache.
Orlistat (Xenical, Alli): Available as both a prescription (Xenical) and over-the-counter formulation (Alli), orlistat is a medication that blocks fats you eat from being absorbed. It’s a capsule taken three times a day with meals. It can cause fatty stools and diarrhea.
Wegovy, Saxenda, and Zepbound are GLP-1 medications that tend to lead to greater weight loss than oral weight loss medications, including Qsymia, Contrave, and orlistat — though they tend to have a higher cash price.
Bottom line
Both Ozempic and phentermine can be used for weight management, but they differ in their FDA-approved uses, mechanisms, side effects, and effectiveness.
Ozempic is a weekly injection or daily pill FDA-approved for people with type 2 diabetes, but it can also reduce appetite and promote significant weight loss. Because of this, Ozempic is often prescribed off-label for weight loss.
Phentermine is an oral pill that can suppress appetite, but it is not safe for some people. It is a mild stimulant that can affect heart rate and blood pressure. It is specifically approved for short-term weight loss.
Other key differences between Ozempic and phentermine include their overall effectiveness, their side effect profiles, and their cost. Ozempic typically leads to greater weight loss, can lead to gastrointestinal side effects, and tends to be more expensive compared to phentermine.
Frequently asked questions (FAQs)
What is Ozempic?
Ozempic (semaglutide) is part of a class of medications called GLP-1s, which stands for glucagon-like peptide-1 receptor agonists. It helps lower blood sugar levels in people with type 2 diabetes, along with diet and exercise. It can also cause weight loss, though it’s technically not FDA-approved for this use.
What is phentermine?
Phentermine is FDA-approved as a short-term weight loss medication. It is a mild stimulant similar to amphetamines and has been available since 1959. Research suggests it might be safe and effective for long-term use for many people.
Is Ozempic approved for weight loss?
No, Ozempic is not FDA-approved for weight loss. However, healthcare providers can prescribe Ozempic off-label when it is the best treatment option. Semaglutide, the active ingredient in Ozempic, can also be prescribed for weight loss under the brand name Wegovy.
How does phentermine help with weight loss?
Phentermine is a mild stimulant that works for weight loss by suppressing appetite. It is meant to be used short-term, up to 12 weeks, but can be used off-label for longer than three months, or on an intermittent schedule (e.g., four weeks "on" then four weeks "off"), only under the guidance of a healthcare provider.
Does phentermine burn fat or suppress appetite?
Phentermine suppresses appetite, rather than burning fat directly. It works for weight loss by releasing the neurotransmitter norepinephrine in the area of the brain that controls appetite, reducing feelings of hunger. It also boosts the number of calories burned at rest. Combined with regular exercise, including resistance training, fat loss is likely.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Ozempic Important Safety Information: Read more about serious warnings and safety info.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
Saxenda Important Safety Information: Read more about serious warnings and safety info.
References
Apovian, C. M., Aronne, L. J., Bessesen, D. H., et al. (2015). Pharmacological management of obesity: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 100(2), 342-362. doi: 10.1210/jc.2014-3415. Retrieved from https://academic.oup.com/jcem/article/100/2/342/2813109
Bansal, A. B., Patel, P., & Al Khalili, Y. (2024). Orlistat. StatPearls. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK542202/
Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet (London, England), 397(10278), 971–984. doi: 10.1016/S0140-6736(21)00213-0. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33667417/
Frías, J. P., Auerbach, P., Bajaj, H. S., et al. (2021). Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): A double-blind, randomised, phase 3B trial. The Lancet: Diabetes & Endocrinology, 9(9), P563-P574. Retrieved from https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00174-1/
Gomez, G. & Stanford, F. C. (2018). US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity. International Journal of Obesity, 42(3), 495–500. doi: 10.1038/ijo.2017.287. Retrieved from https://pubmed.ncbi.nlm.nih.gov/29151591/
Jordan, J., Astrup, A., Engeli, S., et al. (2014). Cardiovascular effects of phentermine and topiramate: A new drug combination for the treatment of obesity. Journal of Hypertension, 32(6), 1178. doi: 10.1097/HJH.0000000000000145. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC4011567/
Kommu, S. & Whitfield, P. (2024). Semaglutide. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK603723/
Lewis, K. H., Fischer, H., Ard, J., et al. (2019). Safety and effectiveness of longer-term phentermine use: clinical outcomes from an electronic health record cohort. Obesity, 27(4), 591–602. doi: 10.1002/oby.22430. Retrieved from https://onlinelibrary.wiley.com/doi/10.1002/oby.22430
Márquez-Cruz, M., Kammar-García, A., Huerta-Cruz, J. C., et al. (2021). Three- and six-month efficacy and safety of phentermine in a Mexican obese population. International Journal of Clinical Pharmacology and Therapeutics, 59(8), 539. doi: 10.5414/CP203943. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8295716/
Miller, C. C., Pandey, A., & Litwin, S. E. (2025). Safety and Efficacy of Phentermine and Topiramate for Weight Loss in Obesity-Related HFpEF. Journal of Cardiac Failure, 31(12), 1888-1891. doi: 10.1016/j.cardfail.2025.08.027. Retrieved from https://www.sciencedirect.com/science/article/abs/pii/S1071916425004622
Moll, H., Frey, E., & Gerber, P., et al. (2024). GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit–harm modelling study. eClinicalMedicine, 73, 102661. doi: 10.1016/j.eclinm.2024.00240. Retrieved from https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00240-2/fulltext
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). (2024). Prescription Medications to Treat Overweight & Obesity. Retrieved from https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
NovoCare. (2026). Find out the cost for Ozempic®. Retrieved from https://www.novocare.com/diabetes/products/ozempic/explaining-list-price.html
Novo Nordisk. (2026). Novo Nordisk's Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US. Retrieved from https://www.prnewswire.com/news-releases/novo-nordisks-ozempic-pill-the-only-fda-approved-oral-peptide-glp-1-medication-for-adults-with-type-2-diabetes-soon-to-be-available-in-the-us-302760106.html
Patel, J. P., Hardaswani, D., Patel, J., et al. (2025). Comparative Effectiveness of Semaglutide, Liraglutide, Orlistat, and Phentermine for Weight Loss in Obese Individuals: A Systematic Review. Cureus, 17(3), e80321. doi: 10.7759/cureus.80321 Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11979670/
Rocha-González, H. I., De la Cruz-Álvarez, L. E., Kammar-García, A., et al. (2021). Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months. Journal of Personalized Medicine, 11(12), 1354. doi: 10.3390/jpm11121354. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8707701/
Røder, M. E. (2019). Clinical potential of treatment with semaglutide in type 2 diabetes patients. Drugs in Context, 8, 212585. doi: 10.7573/dic.212585 Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6905643/
SingleCare. (n.d.). Phentermine HCL Coupons & Prices. Retrieved from https://www.singlecare.com/prescription/phentermine-hcl
U.S. Food and Drug Administration (FDA-a). (2025). Highlights of Prescribing Information: Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/200063s024s026lbl.pdf
U.S. Food & Drug Administration (FDA-b). (2025). Highlights of Prescribing Information: Ozempic (semaglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s035,209637s037lbl.pdf
U.S. Food and Drug Administration (FDA). (2023). Highlights of Prescribing Information: PHENTERMINE hydrochloride capsules USP, for oral use. Retrieved from https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/8a947cf6-c578-0405-e053-2995a90a3e0e/spl-doc
U.S. Food and Drug Administration (FDA-a). (2026). Highlights of Prescribing Information: QSYMIA (phentermine and topiramate extended-release capsules), for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022580s031lbl.pdf
U.S. Food & Drug Administration (FDA-b). (2026). Highlights of Prescribing Information: Rybelsus (semaglutide) tablets for oral use; Ozempic (semaglutide) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213051s030lbl.pdf
U.S. Food and Drug Administration (FDA-c). (2026). Highlights of Prescribing Information: WEGOVY (semaglutide) injection, for subcutaneous use WEGOVY (semaglutide) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s029lbl.pdf
U.S. Food and Drug Administration (FDA-c). (2025). Lomaira phentermine hydrochloride tablet. Retrieved from https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/0718f0f3-77f2-45d7-be12-1ed718c8b806/spl-doc
Yanovski, S. Z. & Yanovski, J. A. (2014). Long-term drug treatment for obesity: a systematic and clinical review. JAMA, 311(1), 74–86. doi: 10.1001/jama.2013.281361 Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC3928674/
Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine, 384(11), 989–1002. doi: 10.1056/NEJMoa2032183. Retrieved from https://www.nejm.org/doi/10.1056/NEJMoa2032183














